STUDY DESIGN: Systematic review and meta-analysis. INTRODUCTION: Prior reviews on the effects of anodal transcranial direct current stimulation (a-tDCS) have shown the effectiveness of a-tDCS on corticomotor excitability and motor function in healthy individuals but nonsignificant effect in subjects with stroke. PURPOSE: To summarize and evaluate the evidence for the efficacy of a-tDCS in the treatment of upper limb motor impairment after stroke. METHODS: A meta-analysis of randomized controlled trials that compared a-tDCS with placebo and change from baseline. RESULTS: A pooled analysis showed a significant increase in scores in favor of a-tDCS (standard mean difference [SMD]=0.40, 95% confidence interval [CI]=0.10-0.70, p=0.010, compared with baseline). A similar effect was observed between a-tDCS and sham (SMD=0.49, 95% CI=0.18-0.81, p=0.005). CONCLUSION: This meta-analysis of eight randomized placebo-controlled trials provides further evidence that a-tDCS may benefit motor function of the paretic upper limb in patients suffering from chronic stroke. LEVEL OF EVIDENCE: Level 1a. Published by Elsevier Inc.
STUDY DESIGN: Systematic review and meta-analysis. INTRODUCTION: Prior reviews on the effects of anodal transcranial direct current stimulation (a-tDCS) have shown the effectiveness of a-tDCS on corticomotor excitability and motor function in healthy individuals but nonsignificant effect in subjects with stroke. PURPOSE: To summarize and evaluate the evidence for the efficacy of a-tDCS in the treatment of upper limb motor impairment after stroke. METHODS: A meta-analysis of randomized controlled trials that compared a-tDCS with placebo and change from baseline. RESULTS: A pooled analysis showed a significant increase in scores in favor of a-tDCS (standard mean difference [SMD]=0.40, 95% confidence interval [CI]=0.10-0.70, p=0.010, compared with baseline). A similar effect was observed between a-tDCS and sham (SMD=0.49, 95% CI=0.18-0.81, p=0.005). CONCLUSION: This meta-analysis of eight randomized placebo-controlled trials provides further evidence that a-tDCS may benefit motor function of the paretic upper limb in patients suffering from chronic stroke. LEVEL OF EVIDENCE: Level 1a. Published by Elsevier Inc.
Authors: Pratik Y Chhatbar; Viswanathan Ramakrishnan; Steven Kautz; Mark S George; Robert J Adams; Wuwei Feng Journal: Brain Stimul Date: 2015-09-07 Impact factor: 8.955
Authors: Manus J Donahue; Eric Achten; Petrice M Cogswell; Frank-Erik De Leeuw; Colin P Derdeyn; Rick M Dijkhuizen; Audrey P Fan; Rashid Ghaznawi; Jeremy J Heit; M Arfan Ikram; Peter Jezzard; Lori C Jordan; Eric Jouvent; Linda Knutsson; Richard Leigh; David S Liebeskind; Weili Lin; Thomas W Okell; Adnan I Qureshi; Charlotte J Stagg; Matthias Jp van Osch; Peter Cm van Zijl; Jennifer M Watchmaker; Max Wintermark; Ona Wu; Greg Zaharchuk; Jinyuan Zhou; Jeroen Hendrikse Journal: J Cereb Blood Flow Metab Date: 2017-08-17 Impact factor: 6.200
Authors: Daniel P Spiegel; Jinrong Li; Robert F Hess; Winston D Byblow; Daming Deng; Minbin Yu; Benjamin Thompson Journal: Neurotherapeutics Date: 2013-10 Impact factor: 7.620